Related Experiment Video
Updated: Jun 18, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction
Shanghai Yu1, Dongguang Qin, Sanjeev Shangary
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
Abstract:
We report herein the design of potent and orally active small-molecule inhibitors of the MDM2-p53 interaction. Compound 5 binds to MDM2 with a K(i) of 0.6 nM, activates p53 at concentrations as low as 40 nM, and potently and selectively inhibits cell growth in tumor cells with wild-type p53 over tumor cells with mutated/deleted p53. Compound 5 has a good oral bioavailability and effectively inhibits tumor growth in the SJSA-1 xenograft model.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Drugs that Destabilize Microtubules
DNA Damage can Stall the Cell Cycle

